R Scott Greer - Net Worth and Insider Trading
R Scott Greer Net Worth
The estimated net worth of R Scott Greer is at least $309,377 dollars as of 2024-05-21. R Scott Greer is the Director of Nektar Therapeutics and owns about 176,574 shares of Nektar Therapeutics (NKTR) stock worth over $309,005. R Scott Greer is the Director of Sientra Inc and owns about 5,266 shares of Sientra Inc (SIENQ) stock worth over $205. R Scott Greer is also the Director of Aravive Inc and owns about 4,179 shares of Aravive Inc (ARAV) stock worth over $168. Details can be seen in R Scott Greer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Scott Greer has not made any transactions after 2020-07-09 and currently still holds the listed stock(s).
Transaction Summary of R Scott Greer
R Scott Greer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Scott Greer owns 6 companies in total, including Nektar Therapeutics (NKTR) , Inogen Inc (INGN) , and Sientra Inc (SIENQ) among others .
Click here to see the complete history of R Scott Greer’s form 4 insider trades.
Insider Ownership Summary of R Scott Greer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2020-07-09 | director |
| INGN | Inogen Inc | 2015-08-03 | director |
| SIENQ | Sientra Inc | 2018-05-07 | director |
 | | 2015-11-11 | director |
| | 2010-06-03 | director |
| | 2003-05-27 | director |
R Scott Greer Latest Holdings Summary
R Scott Greer currently owns a total of 3 stocks. Among these stocks, R Scott Greer owns 176,574 shares of Nektar Therapeutics (NKTR) as of July 9, 2020, with a value of $309,005 and a weighting of 99.88%. R Scott Greer owns 5,266 shares of Sientra Inc (SIENQ) as of May 7, 2018, with a value of $205 and a weighting of 0.07%. R Scott Greer also owns 4,179 shares of Aravive Inc (ARAV) as of November 11, 2015, with a value of $168 and a weighting of 0.05%.
Latest Holdings of R Scott Greer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2020-07-09 | 176,574 | 1.75 | 309,005 |
| SIENQ | Sientra Inc | 2018-05-07 | 5,266 | 0.04 | 205 |
| ARAV | Aravive Inc | 2015-11-11 | 4,179 | 0.04 | 168 |
Holding Weightings of R Scott Greer
R Scott Greer Form 4 Trading Tracker
According to the SEC Form 4 filings, R Scott Greer has made a total of 1 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nektar Therapeutics is the sale of 15,009 shares on July 9, 2020, which brought R Scott Greer around $375,225.
According to the SEC Form 4 filings, R Scott Greer has made a total of 0 transactions in Sientra Inc (SIENQ) over the past 5 years. The most-recent trade in Sientra Inc is the acquisition of 1,111 shares on May 7, 2018, which cost R Scott Greer around $149,998.
According to the SEC Form 4 filings, R Scott Greer has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the acquisition of 1,667 shares on November 11, 2015, which cost R Scott Greer around $101,700.
Insider Trading History of R Scott Greer
- 1
R Scott Greer Trading Performance
GuruFocus tracks the stock performance after each of R Scott Greer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Scott Greer is 0.68%. GuruFocus also compares R Scott Greer's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Scott Greer within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Scott Greer's insider trading performs compared to the benchmark.
Performance of R Scott Greer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.61 | | | | | |
| Relative Return to S&P 500(%) | 11.57 | | | | | |
R Scott Greer Ownership Network
R Scott Greer Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
R Scott Greer is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, R Scott Greer made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 116,554 shares made by Howard W Robin , a net sale of 55,993 shares made by Jonathan Zalevsky , and a net sale of 44,084 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 86,265 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 86,265 shares. During the past 18 months, 291,616 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 291,616 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
R Scott Greer Mailing Address
Above is the net worth, insider trading, and ownership report for R Scott Greer. You might contact R Scott Greer via mailing address: 6207 E. Indian Bend Rd, Paradise Valley Az 85253.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
